Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

Wild Rose/Eglantine 2 X Liquid is a Health Canada–registered human drug (DIN 02246486) held by Alypsis Inc., containing Rosa Canina, Flos. Health Canada lists its status as Cancelled Post Market (status date 14 Jan 2006). Nexara Health has matched 1 registration of Rosa Canina, Flos across 1 other regulated market, 1 of them in the same strength and dosage form.

Health Canada registration

DIN02246486
Brand nameWild Rose/Eglantine
Active ingredientRosa Canina, Flos
Strength2 X
Dosage formLiquid
RouteOral
CompanyAlypsis Inc.
StatusCancelled Post Market — 14 Jan 2006
ClassHuman
ATC
AHFS92:02.00* ; See footnote
Regulator recordHealth Canada DPD entry · Product monograph

Rosa Canina, Flos registered in other markets

1 registration of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.

CountryProductMarketing authorisation holderStrengthFormStatusRegistry
United StatesBio Wild RoseBioActive Nutritional, Inc.LiquidlistedFDA NDC

See every manufacturer of Rosa Canina, Flos worldwide →

Sourcing through Nexara Health

Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.

Frequently asked questions

Is Wild Rose/Eglantine (DIN 02246486) marketed in Canada?

No. Health Canada lists DIN 02246486 as Cancelled Post Market as of 14 Jan 2006.

Who holds the Canadian licence for this product?

Alypsis Inc. is the company of record in the Health Canada Drug Product Database.

Is Rosa Canina, Flos registered outside Canada?

Yes — Nexara Health has matched 1 registration in 1 other market, including 1 in the same strength and dosage form (see the table above).

Where does this data come from?

Health Canada Drug Product Database (DPD), DIN 02246486, status date 2006-01-14; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.

Source: Health Canada Drug Product Database (DPD), DIN 02246486, status date 2006-01-14; national medicine registries: FDA NDC.

Health Canada Drug Product Database (DPD), DIN 02246486, status date 2006-01-14; national medicine registries: FDA NDC. Last reviewed 2026-09-17. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.